Husnu Ceylan

Husnu Ceylan serves as President & CEO at HC Biologics, LLC. HC Biologics, LLC operates in the medical devices sector with approximately 27.0 employees. The company is headquartered in Miami, Florida.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 4,613 executive contacts are available in Florida.
• • Our database includes 201,469 c suite-level executives.

GoDaddy Hosting Google Maps WordPress.org Facebook Widget Facebook Login (Connect) reCAPTCHA Apache Google Font API Bootstrap Framework Mobile Friendly Facebook Custom Audiences Circle

trauma surgery sports medicineacl orthopedic surgery allograft tissue dbm spinal surgery hctps cancellous chips neurologic surgery medical equipment manufacturing biologics orthopedics spinal implants allografts autologous therapies biological matrices hemostats sports medicine surgical implants knee replacement hip replacement spinal solutions trauma care patient safety quality assurance 3d printing custom implants private label manufacturing oem services surgical consultation distributors global distribution compliance iso certification sterilization containers tissue donation surgical training clinical reliability patient outcomes tissue regeneration implant development surgical techniques fracture fixation regulatory support healthcare professionals biologics solutions advanced therapies clinical excellence patient well-being surgical education tissue processing surgical innovation medical technology rehabilitation biologic solutions surgical products rehabilitation solutions tissue engineering medical devices hospital & health care

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Husnu Ceylan in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at HC Biologics, LLC.

Husnu Ceylan's Position in the MessageCEO Database

• •Husnu Ceylan is 1 of 1 verified executive contact we track at HC Biologics, LLC.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •4,408 verified executive contacts in Florida are in the database.
• •35 verified contacts work at medical devices companies in the 27.0 employee range (same size as HC Biologics, LLC).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Husnu Ceylan directly?

Husnu Ceylan's verified email address is available to MessageCEO Pro subscribers. They currently serve as President & CEO at HC Biologics, LLC. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Husnu Ceylan work for?

Husnu Ceylan is President & CEO at HC Biologics, LLC, a company in the medical devices sector with 27.0 employees. The company is based in Miami, Florida.

Can I pitch or sell to Husnu Ceylan?

As President & CEO at HC Biologics, LLC, Husnu Ceylan is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Husnu Ceylan directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Husnu Ceylan in?

Husnu Ceylan works in the medical devices industry as President & CEO at HC Biologics, LLC. MessageCEO provides verified contact information for executives across all major industries.

Is Husnu Ceylan's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Husnu Ceylan's profile is kept up-to-date with the latest available information.

Last updated: July 22, 2026